O'Brien MW - Search Results

1

Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke.

Lansberg MG, Thijs VN, O'Brien MW, Ali JO, de Crespigny AJ, Tong DC, Moseley ME, Albers GW. Lansberg MG, et al. AJNR Am J Neuroradiol. 2001 Apr;22(4):637-44. AJNR Am J Neuroradiol. 2001. PMID: 11290470 Free PMC article.

2

Correlation of perfusion- and diffusion-weighted MRI with NIHSS score in acute (<6.5 hour) ischemic stroke.

Tong DC, Yenari MA, Albers GW, O'Brien M, Marks MP, Moseley ME. Tong DC, et al. Neurology. 1998 Apr;50(4):864-70. doi: 10.1212/wnl.50.4.864. Neurology. 1998. PMID: 9566364

3

MRI abnormalities associated with partial status epilepticus.

Lansberg MG, O'Brien MW, Norbash AM, Moseley ME, Morrell M, Albers GW. Lansberg MG, et al. Neurology. 1999 Mar 23;52(5):1021-7. doi: 10.1212/wnl.52.5.1021. Neurology. 1999. PMID: 10102423

4

Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients.

Albers GW, Lansberg MG, Norbash AM, Tong DC, O'Brien MW, Woolfenden AR, Marks MP, Moseley ME. Albers GW, et al. Neurology. 2000 Apr 25;54(8):1562-7. doi: 10.1212/wnl.54.8.1562. Neurology. 2000. PMID: 10762494 Clinical Trial.

5

Evolution of cerebral infarct volume assessed by diffusion-weighted magnetic resonance imaging.

Lansberg MG, O'Brien MW, Tong DC, Moseley ME, Albers GW. Lansberg MG, et al. Arch Neurol. 2001 Apr;58(4):613-7. doi: 10.1001/archneur.58.4.613. Arch Neurol. 2001. PMID: 11295992

6

Diffusion-weighted MRI in transient global amnesia precipitated by cerebral angiography.

Woolfenden AR, O'Brien MW, Schwartzberg RE, Norbash AM, Tong DC. Woolfenden AR, et al. Stroke. 1997 Nov;28(11):2311-4. doi: 10.1161/01.str.28.11.2311. Stroke. 1997. PMID: 9368581

7

Basilar artery stenosis: clinical and neuroradiographic features.

Woolfenden AR, Tong DC, Norbash AM, Ali AO, Marks MP, O'Brien MW, Albers GW. Woolfenden AR, et al. J Stroke Cerebrovasc Dis. 2000 Mar-Apr;9(2):57-63. doi: 10.1053/jscd.2000.0090057. J Stroke Cerebrovasc Dis. 2000. PMID: 17895197

8

Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia.

Jeng MR, O'Brien M, Wong W, Zoland J, Lea J, Tang N, Glader B. Jeng MR, et al. Haemophilia. 2009 Nov;15(6):1272-80. doi: 10.1111/j.1365-2516.2009.02063.x. Epub 2009 Jul 10. Haemophilia. 2009. PMID: 19601989

9

Updated analysis: central venous access device infection rates in an expanded cohort of paediatric patients with severe haemophilia receiving prophylactic recombinant tissue plasminogen activator.

McCarthy CE, O'Brien M, Andrews J, Zoland JM, Macasiray E, Wong W, Lo C, Glader B, Tamaresis J, Jeng M. McCarthy CE, et al. Haemophilia. 2016 Jan;22(1):81-6. doi: 10.1111/hae.12772. Epub 2015 Aug 7. Haemophilia. 2016. PMID: 26248602

10

An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents.

Genovese MC, Kavanaugh A, Weinblatt ME, Peterfy C, DiCarlo J, White ML, O'Brien M, Grossbard EB, Magilavy DB. Genovese MC, et al. Arthritis Rheum. 2011 Feb;63(2):337-45. doi: 10.1002/art.30114. Arthritis Rheum. 2011. PMID: 21279990 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters